Show simple item record

dc.date.accessioned2019-09-25T15:15:45Z
dc.date.available2019-09-25T15:15:45Z
dc.date.created2016-02-05 13:58
dc.date.issued2016-01-09
dc.identifieroai:repository.library.georgetown.edu:10822/1010498
dc.identifierWashington, DC: GPO [Hearing No. 107-450], 2002 May 8; 61 p.
dc.identifierhttp://timetravel.mementoweb.org/memento/2002/http://www.access.gpo.gov/congress/senate/senate15sh107.html
dc.identifierhttp://hdl.handle.net/10822/1010498
dc.identifier.urihttp://hdl.handle.net/20.500.12424/331361
dc.languageen
dc.language.isoeng
dc.publisherUnited States. Congress. Senate. Committee on Health, Education, Labor and Pensions
dc.sourceeweb:246280
dc.subjectSocial Control of Science and Technology
dc.subjectDrugs and Drug Industry
dc.subjectBusiness Ethics
dc.subjectEconomics of Health Care
dc.titleClosing the Gaps in Hatch-Waxman: Assuring Greater Access to Affordable Pharmaceuticals
ge.collectioncodeBB
ge.collectioncodeBC
ge.dataimportlabelOAI metadata object
ge.identifier.legacyglobethics:7369115
ge.identifier.permalinkhttps://www.globethics.net/gel/7369115
ge.lastmodificationdate2016-03-22 10:47
ge.submissions0
ge.oai.exportid53
ge.oai.repositoryid7270
ge.oai.setnameBioethics Literature and Resources
ge.oai.setnameBioethics Research Library
ge.oai.setnameEthxWeb: Literature in Bioethics
ge.oai.setspeccom_10822_761730
ge.oai.setspeccom_10822_503786
ge.oai.setspeccol_10822_761853
ge.oai.streamid1
ge.setnameGlobeEthicsLib
ge.setspecglobeethicslib
ge.linkhttp://timetravel.mementoweb.org/memento/2002/http://www.access.gpo.gov/congress/senate/senate15sh107.html
ge.linkhttp://hdl.handle.net/10822/1010498


This item appears in the following Collection(s)

Show simple item record